Drugs / simethicone
simethicone
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT04641455 Comparator | Dec 2020 → May 2021 | gastric cancer | Vitkovice Hospital | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | simethicone | “320 mg of simethicone (8 ml of Espumisan sir. 40 mg / ml)administered 20-30 minutes prior to upper endoscopy” NCT04641455 ↗ |
| Known as | ANTIFOAM A | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297192 ↗ |
| Known as | ANTIFOAM AF | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297192 ↗ |
| Known as | Espumisan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04641455 ↗ |